United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2011_register executive 2011-03-16 article Notices D09002ee1c8003293 D09002ee1c800330c United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency Pursuant to 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), this will serve to notify the public that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to intellectual property broker ICAP Ocean Tomo to promote the utilization by the public of the inventions described in the following U.S. patents: 7,122,624 entitled "PH2 Receptor Ligands" (HHS Ref. No. E-123-1999/0), and 7,087,736 entitled "Tyrosine DNA phosphodiesterases (TDP) and related polypeptides, nucleic acids, vectors, TDP producing host cells, antibodies and methods of use" (HHS Ref. No. E-281-1999/0). The patent rights in this invention have been assigned to the United States of America. The prospective exclusive license territory may be worldwide and the field of use may be for the use of the Licensed Patent Rights in developing biopharmaceutical products. 76 FR 14417 https://www.govinfo.gov/app/details/FR-2011-03-16/2011-6124 2011-6124 fr16mr11-93 4140-01-P https://www.govinfo.gov/app/details/FR-2011-03-16/2011-6124 https://www.govinfo.gov/content/pkg/FR-2011-03-16/html/2011-6124.htm https://www.govinfo.gov/content/pkg/FR-2011-03-16/pdf/2011-6124.pdf 2 p. 14417 14418 76 FR 14417 Prospective Grant of Exclusive License; Federal Register Vol. 76, Issue NOTICE 2011-6124 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2011-03-31 4140-01-P 2011-6124 Notice of intent to grant exclusive license.

Pursuant to 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), this will serve to notify the public that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to intellectual property broker ICAP Ocean Tomo to promote the utilization by the public of the inventions described in the following U.S. patents: 7,122,624 entitled "PH2 Receptor Ligands" (HHS Ref. No. E-123-1999/0), and 7,087,736 entitled "Tyrosine DNA phosphodiesterases (TDP) and related polypeptides, nucleic acids, vectors, TDP producing host cells, antibodies and methods of use" (HHS Ref. No. E-281-1999/0). The patent rights in this invention have been assigned to the United States of America. The prospective exclusive license territory may be worldwide and the field of use may be for the use of the Licensed Patent Rights in developing biopharmaceutical products.

Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before March 31, 2011 will be considered. Prospective Grants of Exclusive Licenses: ICAP Ocean Tomo , baharm@mail.nih.gov Vol. 76, no. 51 Office of the Federal Register, National Archives and Records Administration 2011-03-16 continuing daily deposited born digital 315 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2011-03-16 P0b002ee180c3372b 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr16mr11 https://www.govinfo.gov/app/details/FR-2011-03-16 https://www.govinfo.gov/content/pkg/FR-2011-03-16/pdf/FR-2011-03-16.pdf https://www.govinfo.gov/content/pkg/FR-2011-03-16/xml/FR-2011-03-16.xml fdlp 14269 14574 DGPO 2011-03-16 2024-06-04 FR-2011-03-16 machine generated eng FR FR-2011-03-16 76 51